Trial Profile
Effect of Direct-acting Antiviral Drugs on Erectile Function Among Hepatitis c Patients
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Dec 2022
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Sofosbuvir (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- 20 Oct 2020 Protocol of the trial has been amended as the Interventional model has been changed to parallel ,allocation change to randomized, planned pat. number from 2200 to 105 along with the integral changes in primary endpoint and trial indication.
- 20 Oct 2020 Planned number of patients changed from 2200 to 105.
- 27 Feb 2018 New trial record